ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0962

Topological Proteomic Differences in Fibrotic and Unaffected Skin in Scleroderma

Irene Choi1, Courtney Yu2, Francesco Boin1, Elizabeth Volkmann3, Stephanie Stanford2 and Nunzio Bottini4, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2University of California San Diego, San Diego, CA, 3University of California Los Angeles, Los Angeles, CA, 4University of California, San Francisco, CA

Meeting: ACR Convergence 2023

Keywords: autoimmune diseases, Fibrosing syndromes, proteomics, Scleroderma, skin

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (0934–0964) Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Scleroderma (SSc) is a chronic autoimmune and rheumatic disease characterized by varying levels of tissue fibrosis in the skin and other internal organs. It currently has no cure, with little understanding of the pathogenesis of skin fibrosis and an acute need for novel therapeutic targets. Because the skin is a complex, multi-layer organ with diverse functions, it is critical to examine the regional molecular changes throughout each distinct layer to understand the fibrotic processes that occur in the affected skin of SSc patients. To do this, we performed laser capture microdissection (LCM) to separate the epidermis, papillary dermis, and reticular dermis layers from fibrotic and unaffected skin of SSc patients for further proteomic analysis.

Methods: Skin biopsies were collected from fibrotic and unaffected skin of three patients with diffuse SSc (dSSc); subsequently, the epidermis, papillary dermis, and reticular dermis were dissected using LCM. The dissected tissue was digested and subjected to liquid chromatography with tandem mass spectrometry (LC-MS/MS) for proteomic analysis. Univariate and clustering analysis were performed using the MetaboAnalyst 5.0 package. Univariate analysis was performed using fold change analysis and t-test, and hierarchical clustering analysis was performed using Euclidean distance measurements to identify proteins significantly up or downregulated in fibrotic skin compared to unaffected skin for each skin sublayer.

Results: All patients biopsied were female, had been diagnosed with dSSc, had early SSc (< 3 yrs from SSc diagnosis), and were being treated with mycophenolate mofetil. Univariate analysis of fibrotic versus unaffected skin revealed unique proteins that were significantly (p< 0.05) down or upregulated (fold-change >2) in each region. Interestingly, when comparing fibrotic and unaffected papillary dermis we identified a significant downregulation of FAM161B (fold change=-2.4573, p-value< 0.0001), a cilial protein, in all three patients. This is compelling because decreased expression of SPAG17, another cilial protein, has been correlated with increased skin fibrosis in SSc patients. Importantly, none of the differentially expressed proteins in the distinct skin layers overlapped with each other, confirming that fibrosis affects the microenvironments of the skin layers in SSc patients.

Conclusion: Through the use of LCM, we established a method for proteomic analysis of substructures from fibrotic and unaffected skin of SSc patients. This technology can be used to complement single-cell spatial transcriptomics to provide key information on in situ gene expression profiles and identify disease and substructure-specific targets for SSc skin fibrosis.

Supporting image 1

Figure 1: FAM161B is significantly downregulated in papillary dermis of fibrotic skin. Fibrotic and unaffected skin biopsies from patients with SSc (n=3) were subjected to LCM to isolate the papillary dermis, then LC-MS/MS for proteomic analysis. The graph shows fold-change for FAM161B  normalized to non-fibrotic protein intensity. Statistical significance was assessed using two-tailed paired t test, ***p<0.0001


Disclosures: I. Choi: None; C. Yu: None; F. Boin: None; E. Volkmann: Boehringer-Ingelheim, 2, 5, 6, CSL Behring, 2, GlaxoSmithKline, 2, Horizon, 5, Prometheus, 5, Roche, 2; S. Stanford: None; N. Bottini: Thirona Bio, 2.

To cite this abstract in AMA style:

Choi I, Yu C, Boin F, Volkmann E, Stanford S, Bottini N. Topological Proteomic Differences in Fibrotic and Unaffected Skin in Scleroderma [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/topological-proteomic-differences-in-fibrotic-and-unaffected-skin-in-scleroderma/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/topological-proteomic-differences-in-fibrotic-and-unaffected-skin-in-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology